UAB study finds potential treatment target for Guillain-Barre syndrome
Tuesday, August 23, 2016 - 01:01
in Health & Medicine
Investigators at UAB have identified an intriguing potential treatment target for the most common form of Guillain-Barre syndrome. In a new study, the authors offer evidence of a crucial pathogenic role for a molecule that is associated with AIDP, the most common variant of Guillain-Barre syndrome.
